HC
Hemalatha Cherukuneedi
About Hemalatha Cherukuneedi
Hemalatha Cherukuneedi has 7 years in corporate governance. Holds Director role. Currently with 6 companies, including Vercali Pharma Private Limited and Uday Aqua Connects Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Vercali Pharma Private Limited
U24239TG2019PTC131713
|
Director | 29 Mar 2019 | 2019 | Under Process Of Striking Off |
Uday Aqua Connects Private Limited
U05000TG2019PTC136662
|
Director | 07 Nov 2019 | 2019 | Active |
Uday Aqua International Private Limited
U03220AP2025PTC118366
|
Director | 18 Mar 2025 | 2025 | Active |
Kolleru Aqua Diagnostic & Research Lab Private Limited
U05000AP2019PTC112079
|
Director | 15 Sep 2023 | 2019 | Under Process Of Striking Off |
Bioaaa It Private Limited
U72900AP2019PTC113675
|
Director | 15 Sep 2023 | 2019 | Under Process Of Striking Off |
Cherukuneedi Foundation
U88900TS2023NPL175264
|
Director | 21 Jul 2023 | 2023 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemalatha Cherukuneedi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemalatha Cherukuneedi
Hemalatha Cherukuneedi has 7 years in corporate governance. Holds Director role. Currently with 6 companies, including Vercali Pharma Private Limited and Uday Aqua Connects Private Limited. Engaged in General Business. Contributes to corporate operations.
Hemalatha Cherukuneedi is associated with 6 companies as Director.
Hemalatha Cherukuneedi has expertise in General Business.
Hemalatha Cherukuneedi has 7 years in corporate governance.